Walgreens Weight Management review
Walgreens Weight Management in brief
Walgreens Weight Management is pay-per-visit telehealth: $49 for each video or chat visit, no subscription, and FDA-approved brand-name drugs only, from $149 a month for Wegovy pills with a manufacturer savings offer. It suits cash-pay adults in its 28 states who want a big-name pharmacy; it does not handle insurance or Medicare.
- Price$49 per visit + from $149/mo medication
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- From $149/mo (Wegovy pills, brand-name self-pay; visits billed separately)
- Tirzepatide
- From $299/mo (Zepbound KwikPens, brand-name self-pay; visits billed separately)
- Coverage
- 28 states
- Brand-name
- Yes
Walgreens Weight Management pricing
As listed on Walgreens Weight Management's own site, October 2026.
| Plan | Price | Billing | What's included |
|---|---|---|---|
| Video or chat visit | Price $49 per visit | Billing Pay per visit, no subscription | Includes Clinician review, treatment plan, prescription if appropriate |
| Wegovy pills or Foundayo pills | Price From $149/mo | Billing Paid at the pharmacy with a manufacturer self-pay offer | Includes Lowest dose; higher doses $199 to $299/mo |
| Wegovy injectable pens | Price From $199/mo | Billing Introductory self-pay offer for the first two months | Includes Later doses up to $349/mo |
| Zepbound KwikPens | Price From $299/mo | Billing Self-pay offer through December 2026 | Includes Higher doses $399 to $449/mo |
Our take on Walgreens Weight Management
Walgreens runs this program on its virtual care platform, with visits handled by affiliated medical practices that are owned and run by licensed physicians. There is no membership. You complete a short health questionnaire, and if you qualify you go straight into an on-demand video visit with a doctor or nurse practitioner. That first visit is $49. Most follow-ups after that happen by chat, and each chat or extra video visit is another $49. Over a typical first quarter with a monthly check-in, plan on roughly $150 in visit fees on top of the medication.
The menu is brand-name only, and that is the defining difference from the many cash-pay clinics selling compounded shots. Walgreens lists Wegovy as a daily pill and a weekly pen, Zepbound in KwikPens and vials, Foundayo (orforglipron) as a daily pill, and Saxenda. No compounded semaglutide or tirzepatide is offered. Medication is not included in the visit fee; you pay the pharmacy, and Walgreens points self-pay patients to the drugmakers' own cash offers.
Those offers set the real monthly cost. As Walgreens describes them, Wegovy pills start at $149 a month at the lowest dose and run $199 to $299 at higher doses. Foundayo follows the same $149 to $299 ladder. Wegovy injections are as low as $199 a month for the first two months, then up to $349. Zepbound KwikPens start at $299 and climb to $399 to $449. Several of these are labeled limited-time and run through December 31, 2026, so check them again before you budget past the new year.
The gaps are clear and Walgreens states them itself. The telehealth service does not bill insurance, does not do prior authorizations, and does not see Medicare patients yet, though the Walgreens pharmacy fills Medicare GLP-1 Bridge prescriptions at $50 a month for those who qualify through another prescriber. And it is only live in 28 states, so check yours first.
Signing up, paying and canceling
What Walgreens Weight Management's own site shows a new patient.
- The first step is an online questionnaire that screens on BMI and weight-related conditions; if you pass, you are routed into an on-demand video visit rather than a scheduled appointment.
- Every visit is billed on its own at $49, video or chat, and there is nothing to cancel because nothing recurs; you simply stop booking visits.
- Walgreens lists 28 states where the service runs, including California, Florida, New York and Texas; whether you get chat or video depends on your state.
- The cheapest prices quoted depend on drugmaker self-pay offers that bar you from using insurance or Medicare for the same fill.
The scorecard
Walgreens Weight Management scored on our six published factors. See the methodology.
What we like
- Brand-name only: Wegovy pills from $149/mo and Zepbound KwikPens from $299/mo
- No subscription — pay per visit
The caveats
- Each video or chat visit costs $49 on top of the drug
- Does not bill insurance or Medicare
Walgreens Weight Management: common questions
How much does Walgreens Weight Management cost?
Each video or chat visit costs $49, with no subscription. Medication is separate and paid at the pharmacy: Wegovy pills and Foundayo start at $149 a month, Wegovy injections at $199, and Zepbound KwikPens at $299, all through drugmaker self-pay offers that rise at higher doses.
Does Walgreens Weight Management take insurance?
No. Walgreens says the telehealth service is for people paying out of pocket and does not bill insurance, Medicare or handle prior authorizations for GLP-1s. Medicare patients can still fill Bridge program prescriptions from another prescriber at a Walgreens pharmacy.
What states does Walgreens Weight Management serve?
Walgreens lists 28 states, among them Arizona, California, Florida, Georgia, Illinois, Michigan, New Jersey, New York, Ohio, Pennsylvania, Texas, Virginia and Washington. If your state is missing, the online visit is not available to you yet.
Does Walgreens sell compounded semaglutide?
No. When we read the Walgreens weight loss page in October 2026, every option was an FDA-approved brand-name drug: Wegovy, Zepbound, Foundayo and Saxenda. If you want compounded semaglutide or tirzepatide, you would need a different telehealth provider.
The verdict
Best for: Shoppers who want mainstream telehealth GLP-1 access. Walgreens pay-per-visit virtual care prescribing brand-name GLP-1s at self-pay prices, filled through its retail pharmacy network.
Ranked #402 of 548 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, ranked #1. In the ranking it sits between T2D.com at #401, 58/100 above and Aspen at #403, 57/100 below, with the Embody write-up the next one down.
A grade C is a ranking, not an instruction to stop looking: the closest rivals to Walgreens Weight Management are scored on the identical rubric, so the comparison is like for like. If you would rather start from the top of the field, our full board of 548 providers is the place to start if you are still shortlisting. We have also compared it head to head: CoreAge Rx vs Walgreens Weight Management goes to CoreAge Rx, 94/100 to 58/100.
Compare Walgreens Weight Management
Compare with other providers
The closest reviews to Walgreens Weight Management by Verdict Score — the realistic shortlist if you are weighing this one up.
- #399Medi-Weightloss— Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.58/100
- #400Push Health— A clinician messaging and prescription platform with variable care fees; medication is purchased separately from your chosen pharmacy.58/100
- #401T2D.com— T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.58/100
- #403Aspen— Publishes every price tier before intake, but its 'monthly' plan bills three months upfront, the provider picks your molecule, and Mississippi and Louisiana are excluded.57/100
- #404Embody— Advertises low promotional compounded GLP-1 prices, while its own terms list different program schedules.57/100
- #405Nolu— An all-in per-order price with a rare oral route — but every figure on the site is billed per 4 weeks, not by the calendar month.57/100
Pricing, states and verification reflect Walgreens Weight Management's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Walgreens Weight Management's site. Not medical advice; see our disclosure.